logo-loader
CVE:LXG

Lexagene Holdings Inc

Receive alerts
Market:
CVE
Market Cap:
$45.79 m
Price
$0.64
Change
3.23%
52 weeks high
0.93
52 weeks low
0.50

In brief

LexaGene is a biotechnology company developing a fully automated pathogen detection platform for use at the site of sample collection, which offers unprecedented ease-of-use, sensitivity, and breadth of pathogen detection. LexaGene’s technology aims to transform the way organizations prevent and diagnose disease in multi-billion dollar markets such as food safety, veterinary diagnostics, water quality monitoring, aquaculture pathogen surveillance, and more.